Explore the cutting-edge science and breakthroughs from the T-cell Lymphoma Forum, where researchers battle this complex form of cancer using precision medicine and cellular engineering.
Exploring the phase I/II study of pembrolizumab for progressive diffuse large B-cell lymphoma after CAR-T therapy failure, including mechanisms, clinical trial data, and future directions.
Exploring the critical process of translational research that bridges scientific discoveries to real-world medical treatments, with a focus on the groundbreaking CAR-T cell therapy.